On Tuesday, biotech and pharmaceutical companies urged president Donald Trump to reconsider his decision to end former president Barack Obama’s policy protecting undocumented immigrants who arrived in the U.S. as children.
Attorney general Jeff Sessions said Tuesday morning that Trump would move to halt the Deferred Action for Childhood Arrivals program in six months, unless Congress moves to protect it. The president & CEO of Decibel Therapeutics, Steven Holtzman, and the president & CEO of Ovid Therapeutics, Jeremy Levin, called on the president to “reverse your decision” in a letter that has since received add-on signatures from folks like the CEO of Biogen (NSDQ:BIIB), Michel Vounatsos.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.